Edward R. O’Brien

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 589 citations

Medicine, Oncology, Pharmacology +15

A Citywide Protocol for Primary PCI in ST-Segment Elevation Myocardial Infarction

Michel R. Le May, Derek So, Richard Dionne et al. · New England Journal of Medicine · 2008 · 436 citations · Full text

Medicine, Cardiology, Surgery +13

Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trial

Jason D. Roberts, George A. Wells, Michel R. Le May et al. · The Lancet · 2012 · 391 citations

Medicine, Genetics, Molecular Genetics +17

Proliferation in primary and restenotic coronary atherectomy tissue. Implications for antiproliferative therapy.

Edward R. O’Brien, Charles E. Alpers, Douglas K. Stewart et al. · Circulation Research · 1993 · 365 citations · Full text

Medicine, Pathobiology, Pathology +15

Detection of Chlamydia pneumoniae TWAR in Human Coronary Atherectomy Tissues

Lee Ann Campbell, Edward R. O’Brien, A Cappuccio et al. · The Journal of Infectious Diseases · 1995 · 345 citations

Medicine, Microbiology, Pathology +16